DAL vs IMRX · P/E 12, rev $61.64B vs $124.2M cap
Delta Air Lines Inc (DAL) versus Immuneering Corp (IMRX) — a side-by-side from cached financials, not a winner call.
Delta Air Lines Inc (DAL) is a airlines company listed on US. It is led by Ed Bastian.
Immuneering Corp (IMRX) is a biotechnology company listed on US.
Latest reported DAL revenue for 2024-12-31 was $61.64B. Net income was $3.46B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
Latest reported IMRX revenue for 2023-12-31 was $0. Net income was -$53.5M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. IMRX currently screens at market cap $124.2M.
DAL currently screens at market cap $52.18B and trailing P/E 11.6. IMRX currently screens at market cap $124.2M.
Not investment advice. Open the DAL and IMRX stock pages for the full models.
Not investment advice.